In the active group we found increased expression of the key gene of insulin action PI3 kinase (1.5-fold) and decreased expressions of the T2D markers RRAD and TGFB3 (0.53–0.54-fold). The gene discussed is INS; the disease is type 2 diabetes mellitus.